Digoxin and Digoxigenin

Digoxin Pharmacology

Digoxin acts directly on myocardial and vascular smooth muscle, indirectly increasing myocardial contractility, slowing heart rate, and decreasing AV node conduction. Its mechanism of action is through inhibition of Na⁺/K⁺ ATPase on the cardiomyocyte membrane, leading to an increase in intracellular sodium ion concentration. This process inhibits the calcium exchange mechanism, resulting in an increase in intracellular calcium ion concentration, which enhances myocardial contractility (positive inotropic effect). Digoxin also improves blood circulation to the kidneys, increases urine formation, and makes it easier to excrete excess water, thus reducing swelling of the lower extremities, breathing difficulties, and improving physical performance.

Digoxin also reduces heart rate by enhancing vagal tone. This effect is achieved by inhibiting Na⁺/K⁺ ATPase in vagal afferent fibers, with the resultant slowing of sinus node autoregulation and atrioventricular node conduction velocities, which is effective in controlling tachyarrhythmias such as atrial fibrillation and atrial flutter. This electrophysiologic effect makes digoxin particularly important in the treatment of patients with atrial fibrillation accompanied by a rapid ventricular response. The effects of digoxin on the neuroendocrine system should not be overlooked. It increases the sensitivity of carotid sinus pressure receptors, inhibits sympathetic activity, and decreases the activity of the renin-angiotensin-aldosterone system. These effects help to improve symptoms in patients with heart failure, especially in long-term therapy.

Digoxin is usually administered orally with a bioavailability of approximately 60% to 80% and is rapidly absorbed in the body after oral administration. Approximately 25% of digoxin is bound to serum albumin. Because digoxin is extensively bound to muscle tissue, it has a large volume of distribution. Digoxin penetrates the cerebrospinal fluid and crosses the placental barrier into breast milk. Digoxin has an onset of action of approximately 2 hours after oral administration, peaks approximately 6 hours after administration, and is excreted primarily through the kidneys; therefore, it should be used with caution in patients with renal insufficiency.

Applications of DIG in Biotechnology

The unique chemical properties of DIG make it a highly efficient immunolabel, which is widely used in various experiments, such as in situ hybridization (ISH), enzyme-linked immunosorbent assay (ELISA), etc. The use of DIG not only improves the sensitivity of the experiments, but also reduces the dependence on radioisotopes. In molecular cloning, DIG is used as a ligand that can be bound to DNA and RNA probes and detected after hybridization with anti-DIG-antibody enzyme couplers. Thus, digoxigenin-labeled probes can be used for Southern, Northern and dot blot hybridization. DIG is commonly used in ISH technology to detect specific RNA or DNA sequences in cells or tissues. In this process, DIG-labeled probes are visualized by anti-DIG antibodies after binding to the target sequence. This method is highly sensitive and specific, enabling analysis at the single-cell level.

Table 1. Methods of labeling nucleic acids with DIG

(Source: Green MR, et al. 2022)

In ELISA, DIG can be used as a marker that binds to an antibody and is used to detect the target protein in the sample. Quantitative analysis of target protein concentration is achieved by generating measurable signals through enzymatic reactions. This method is widely used in clinical diagnosis and research. PCR-FISH combines PCR amplification and in situ hybridization techniques to accurately localize specific genes within cells using DIG-labeled probes. High-affinity DIG-specific antibodies were raised after immunizing sheep with the DIG-coated protein edestin or bovine serum albumin. The most versatile immunological reagent for the detection of DIG-labeled probes is a Fab (fragment antigen-binding) fragment of anti-DIG immunoglobulin coupled to alkaline phosphatase.

DIG as a marker is characterized by non-radioactivity, high sensitivity, and broad applicability, but the use of DIG requires attention to the issue of specificity, and in some cases, DIG may bind to non-target molecules, resulting in false-positive results. The optimal concentration and reaction time of DIG-labeled probes under different experimental conditions need to be optimized to ensure reliable results. In addition, DIG-related reagents are relatively expensive, which may limit their use in some laboratories.